Under fire, Pfizer hits back as weighs next Astra move
[Reuters – UK Focus] – * CEO says UK science a key attraction of AstraZeneca (NYSE: AZN – news) deal * Investors waiting for sweetened bid, possibly next week (Adds further Pfizer CEO quotes, AstraZeneca comment, background) LONDON, May 10 (Reuters) – U. more
View todays social media effects on AZN
View the latest stocks trending across Twitter. Click to view dashboard